Literature DB >> 16787419

Chaperone protein 14-3-3 and protein kinase A increase the relative abundance of low agonist sensitivity human alpha 4 beta 2 nicotinic acetylcholine receptors in Xenopus oocytes.

Richard Exley1, Mirko Moroni, Federica Sasdelli, Lee M Houlihan, Ronald J Lukas, Emanuele Sher, Ruud Zwart, Isabel Bermudez.   

Abstract

Alpha4 and beta2 nicotinic acetylcholine (nACh) receptor subunits expressed heterologously in Xenopus oocytes assemble into a mixture of receptors with high and low agonist sensitivity whose relative abundance is influenced by the heteropentamer subunit ratio. We have found that inhibition of protein kinase A by KT5720 decreased maximal [3H]cytisine binding and acetylcholine (ACh)-induced current responses, and increased the relative proportion of alpha4beta2 receptors with high agonist sensitivity. Mutation of serine 467, a putative protein kinase A substrate in a chaperone protein binding motif within the large cytoplasmic domain of the alpha4 subunit, to alanine or asparate decreased or increased, respectively, maximal [3H]cytisine binding and ACh response amplitude. Expression of alpha4S467A mutant subunits decreased steady levels of alpha4 and the relative proportion of alpha4beta2 receptors with low agonist sensitivity, whilst expression of alpha4S467D increased steady levels of alpha4 and alpha4beta2 receptors with low agonist sensitivity. Difopein, an inhibitor of chaperone 14-3-3 proteins, decreased [3H]cytisine binding and ACh responses and increased the proportion of alpha4beta2 with high sensitivity to activation by ACh. Thus, post-translational modification affecting steady-state levels of alpha4 subunits provides a possible means for physiologically relevant, chaperone-mediated variation in the relative proportion of high and low agonist sensitivity alpha4beta2 nACh receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787419     DOI: 10.1111/j.1471-4159.2006.03915.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat.

Authors:  Jonathan M Beckel; Lori A Birder
Journal:  J Physiol       Date:  2012-01-16       Impact factor: 5.182

Review 2.  Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Authors:  R Exley; S J Cragg
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

3.  Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression.

Authors:  A-L Carbone; M Moroni; P-J Groot-Kormelink; I Bermudez
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

4.  Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors.

Authors:  A J Thompson; K L Price; S C R Lummis
Journal:  J Physiol       Date:  2011-06-27       Impact factor: 5.182

Review 5.  Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses.

Authors:  Ju Wang; Wenji Yuan; Ming D Li
Journal:  Mol Neurobiol       Date:  2011-09-16       Impact factor: 5.590

6.  Potentiation of a neuronal nicotinic receptor via pseudo-agonist site.

Authors:  Simone Mazzaferro; Isabel Bermudez; Steven M Sine
Journal:  Cell Mol Life Sci       Date:  2019-01-01       Impact factor: 9.261

7.  Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells.

Authors:  Paraskevi Krashia; Mirko Moroni; Steven Broadbent; Giovanna Hofmann; Sebastian Kracun; Marco Beato; Paul J Groot-Kormelink; Lucia G Sivilotti
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

Review 8.  Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Authors:  Christie D Fowler; Michael A Arends; Paul J Kenny
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

9.  Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome.

Authors:  Joao A Paulo; William J Brucker; Edward Hawrot
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

10.  Non-agonist-binding subunit interfaces confer distinct functional signatures to the alternate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation.

Authors:  Mirko Moroni; Ranjit Vijayan; Anna Carbone; Ruud Zwart; Philip C Biggin; Isabel Bermudez
Journal:  J Neurosci       Date:  2008-07-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.